Sign In  |  Register  |  About Daly City  |  Contact Us

Daly City, CA
September 01, 2020 1:20pm
7-Day Forecast | Traffic

  • Search Hotels in Daly City

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Biogen Inc

Recent news which mentions Biogen Inc

< Previous 1 2 3 Next >
Alzheimer's drug Leqembi promises to give patients more time, but they face a long road to treatment
Tags Biotech and Pharmaceuticals Health care industry Eisai Co Ltd
From CNBC.com News
Biogen beats expectations, hikes outlook as Alzheimer's drug Leqembi and other new products gain traction
Tags Companies US: News Biotechnology
From CNBC.com News
Patients on Alzheimer's drug Leqembi see benefits over three years, Eisai study says
Tags Health care industry Eisai Co Ltd Biotech and Pharmaceuticals
From CNBC.com News
Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says
Tags Health care industry Eli Lilly and Co Eisai Co Ltd
From CNBC.com News
European drug regulator rejects Alzheimer's treatment Leqembi from Biogen, Eisai
Tags Eli Lilly and Co Eisai Co Ltd Health care industry
From CNBC.com News
Jim Cramer says Eli Lilly isn't a 'one trick pony' after FDA advisers endorse its Alzheimer's drug
Tags Markets Investment strategy Stock Picks
From CNBC.com News
Cramer's Lightning Round: Bank of America is a buy
Tags Bank of America Corp Mad Money S&P 500
From CNBC.com News
Biogen tops quarterly profit estimates as cost cuts take hold, Leqembi launch picks up
Tags Biotech and Pharmaceuticals Earnings Eisai Co Ltd
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Microsoft Corp Raytheon Technologies Corp Exxon Mobil Corp
From CNBC.com News
Eli Lilly says FDA delays approval of Alzheimer's drug in surprise move
Tags Business News Health & Science Biogen Inc
From CNBC.com News
Healthy Returns: The launch of breakthrough Alzheimer’s drug Leqembi is off to a slow start
Tags Biogen Inc Biotech and Pharmaceuticals Health & Science
From CNBC.com News
Biogen revenue and profit shrink on Aduhelm costs, slumping sales of multiple sclerosis therapies
Tags Eisai Co Ltd Health care industry Earnings
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Markets Verizon Communications Inc Restaurant Brands International Inc
From CNBC.com News
Biogen drops controversial Alzheimer's drug Aduhelm to focus on Leqembi, experimental treatments
Tags Biotech and Pharmaceuticals Health care industry Eisai Co Ltd
From CNBC.com News
Weight loss drugs, Alzheimer's treatments and gene editing: Enormous firsts defined 2023 in pharma
Tags Business Pharmaceuticals US: News
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Economy Biogen Inc Investing
From CNBC.com News
More convenient form of breakthrough Alzheimer's drug Leqembi shows promising results in study
Tags Biotech and Pharmaceuticals Eisai Co Ltd Health care industry
From CNBC.com News
Sage Therapeutics stock plunges 48% after FDA decision on postpartum depression drug
Tags Drug approvals SAGE Therapeutics Inc Pharmaceuticals
From CNBC.com News
Stocks making the biggest moves premarket: Intel, Roku, Procter & Gamble and more
Tags Mondelez International Inc Breaking news Ford Motor Co
From CNBC.com News
Stocks making the biggest moves midday: Spotify, RTX, General Electric and more
Tags 3M Co Biogen Inc Spotify Technology SA
From CNBC.com News
Biogen to cut 1,000 jobs to save costs as company prepares for Leqembi launch
Tags Health & Science Biotech and Pharmaceuticals Business News
From CNBC.com News
5 things to know before the stock market opens Tuesday
Tags Business 5 Things to Know Morgan Stanley
From CNBC.com News
Eli Lilly expects FDA decision on Alzheimer's treatment donanemab by the end of the year
Tags Biotech and Pharmaceuticals Eisai Co Ltd Health care industry
From CNBC.com News
Medicare will pay for Alzheimer's drug Leqembi. What patients and doctors should know
Tags US: News Social issues Biogen Inc
From CNBC.com News
Sales of Alzheimer’s drug Leqembi may be slow initially but could pick up in 2024
Tags Biotech and Pharmaceuticals Regulations Health care industry
From CNBC.com News
Stocks making the biggest moves midday: Rivian, Levi Strauss, Biogen, First Solar and more
Tags First Solar Inc Eisai Co Ltd Alibaba Group Holding Ltd
From CNBC.com News
Stocks making the biggest premarket moves: Levi Strauss, Biogen, Alibaba and more
Tags Meta Platforms Inc Costco Wholesale Corp Economy
From CNBC.com News
Japanese pharma Eisai slides 4% despite FDA approval for Alzheimer's drug
Tags World Markets Pharmaceuticals Asia Markets
From CNBC.com News
FDA approves Alzheimer’s drug Leqembi, paving way for broader Medicare coverage
Tags US: News Social issues Biotechnology
From CNBC.com News
Stocks making the biggest moves midday: JD.Com, Biogen, Oracle and more
Tags Market Insider Markets Royal Caribbean Cruises Ltd
From CNBC.com News
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 DalyCity.com & California Media Partners, LLC. All rights reserved.